Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,251 across all filing types
Latest filing 2016-12-02 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
招商证券股份有限公司关于公司转让江西昌九化工集团有限公司股权相关事项的专项意见
Capital/Financing Update Classification · 95% confidence The document is a detailed special opinion report by a financial advisor (招商证券股份有限公司) regarding the transfer of equity in 江西昌九化工集团有限公司 by 赣州工业投资集团有限公司. It discusses compliance with prior commitments, legality, preconditions, and risks related to the equity transfer. The content focuses on a specific transaction, including regulatory approvals, risk factors, and procedural details. It is not a general financial report, earnings release, or management discussion. It is not a brief announcement or a proxy statement. The document is a specialized advisory opinion related to a capital transaction but does not announce a new financing or capital structure change per se. It is not a merger or acquisition filing but relates to a share transfer. Given the detailed nature and focus on the transaction and related risks, it fits best under Capital/Financing Update (CAP). The document length (4049 characters) is sufficient for a substantive report rather than a mere announcement. Therefore, the classification is CAP with high confidence.
2016-12-02 Chinese
重大事项进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding a significant development related to the planned transfer of controlling shareholder equity. It discusses risks, the status of the equity transfer, stock suspension, and potential delisting risks. The document is relatively short (925 characters) and serves as an update on a corporate event rather than a full financial report or detailed filing. It does not contain financial statements or detailed management discussion. The content aligns with a Regulatory Filing (RNS) as it is a general regulatory announcement about a corporate event and risk disclosure without fitting into more specific categories like M&A filings or delisting announcements. Although delisting risk is mentioned, this is a risk warning and not an official delisting announcement, so DLST is not appropriate. Therefore, the best classification is Regulatory Filings (RNS).
2016-12-02 Chinese
关于上海证券交易所《关于对江西昌九生物化工股份有限公司有关股权转让事项重大风险的问询函》的回复公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding the risks and progress related to a major equity transfer involving the company and its controlling shareholder. It discusses the background of previous failed asset restructurings, the current equity transfer plan, associated risks including regulatory approvals, market risks, and potential impacts on the company's control and stock listing status. The document includes detailed disclosures, risk warnings, and procedural updates related to the equity transfer process. It is not a financial report, earnings release, or audit report, but rather a regulatory announcement about a significant corporate transaction and its risks. The document is lengthy and comprehensive, clearly intended as a formal regulatory disclosure to inform investors and the market about the equity transfer and associated risks. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2016-12-02 Chinese
关于公司股票复牌的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (974 characters) regarding the resumption of trading (stock resumption) of the company's shares after a suspension due to a major event involving potential change in control. It references prior suspension announcements and inquiry letters from the stock exchange, and states the date when trading will resume. There are no financial statements, detailed financial data, or report contents. The document is an official notice about stock trading status, specifically a resumption announcement after suspension. This fits the category of Regulatory Filings (RNS) as it is a regulatory announcement about stock trading status and related disclosures, not a full report or financial statement.
2016-12-02 Chinese
赣州工业投资集团有限公司关于在江西省产权交易所公开转让昌九集团股权进行信息预披露的通知
Capital/Financing Update Classification · 95% confidence The document is a notification from a state-owned investment group about the pre-disclosure of information related to the public transfer of equity in a subsidiary company. It references regulatory requirements for state-owned asset transactions and provides detailed information about the equity transfer, including shareholder structure, approval documents, financial data, and contact information. The document is not a full financial report but rather an announcement of an upcoming equity transfer and related disclosures. It fits the category of Capital/Financing Update (CAP) because it concerns a significant change in capital structure through equity transfer and public listing of shares for sale.
2016-12-02 Chinese
赣州市国有资产监督管理委员会关于股权转让事项重大风险问询函的回复
Regulatory Filings Classification · 95% confidence The document is a formal reply from a government supervisory committee regarding a risk inquiry about a significant equity transfer. It discusses risks related to market conditions and approval processes for the transfer of a major shareholding. There is no indication that this is a full financial report, audit, or earnings release. It is a regulatory communication addressing a specific transaction risk and approval status. The content fits best under Regulatory Filings (RNS) as it is a regulatory announcement and does not match other more specific categories like M&A filings or major shareholding notifications, since it is a risk inquiry response rather than a direct transaction announcement.
2016-12-02 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.